WO2002008284A2
(en)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
WO2000053756A2
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
GB9701684D0
(en)
|
1997-01-28 |
1997-03-19 |
Smithkline Beecham Plc |
Novel compounds
|
WO2000053751A1
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2000053754A1
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor
|
US6579520B2
(en)
*
|
1998-05-15 |
2003-06-17 |
Genentech, Inc. |
IL-17 related mammalian cytokine polypeptides (IL-17E)
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
US6358508B1
(en)
|
1997-06-11 |
2002-03-19 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR9
|
US6949358B1
(en)
|
1997-06-11 |
2005-09-27 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor TR9
|
CN1270637A
(zh)
*
|
1997-08-08 |
2000-10-18 |
华盛顿大学 |
新的衰老因子基因p23的分离
|
US20030073169A1
(en)
|
1997-09-18 |
2003-04-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030069178A1
(en)
|
1997-10-17 |
2003-04-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7105640B2
(en)
|
1997-10-17 |
2006-09-12 |
Genentech, Inc. |
Anti-pro792 antibodies
|
US7195760B2
(en)
|
1997-10-17 |
2007-03-27 |
Genentech, Inc. |
Anti-pro363 antibodies
|
US6391311B1
(en)
*
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
US6808890B2
(en)
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
US8007798B2
(en)
|
1997-11-21 |
2011-08-30 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
ES2305608T3
(es)
*
|
1997-11-21 |
2008-11-01 |
Genentech, Inc. |
Antigenos tipo a-33 y sus utilizaciones farmacologicas.
|
CA2309897A1
(en)
|
1997-11-22 |
1999-06-03 |
Hyseq, Inc. |
A novel egf motif protein obtained from a cdna library of fetal liver-spleen
|
US7033772B1
(en)
|
1998-01-15 |
2006-04-25 |
Millennium Pharmaceuticals, Inc. |
Methods of identifying inhibitors of fatty acid transport proteins (FATP)
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
US6203979B1
(en)
|
1998-01-16 |
2001-03-20 |
Incyte Pharmaceuticals, Inc. |
Human protease molecules
|
US7045333B1
(en)
|
1998-01-16 |
2006-05-16 |
Incyte Corporation |
Human protease molecules
|
EP1054958A4
(en)
|
1998-02-06 |
2003-01-08 |
Human Genome Sciences |
Human serine protease and serpin polypeptides
|
ES2389387T3
(es)
|
1998-03-17 |
2012-10-25 |
Genentech, Inc. |
Polipéptidos homólogos de VEGF y de BMP1
|
US7067636B2
(en)
|
1998-05-06 |
2006-06-27 |
Genentech, Inc. |
Anti-pro 1017 antibodies
|
US7081521B2
(en)
|
1998-05-06 |
2006-07-25 |
Genentech, Inc. |
Anti-PRO788 antibodies
|
US7488795B2
(en)
|
1998-05-07 |
2009-02-10 |
Genentech, Inc. |
PRO846 polypeptides
|
US20030186368A1
(en)
|
1998-05-13 |
2003-10-02 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP3577586B2
(ja)
|
1998-05-15 |
2004-10-13 |
ジェネンテック・インコーポレーテッド |
Il−17相同的ポリペプチドとその治療用途
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
EP3112468A1
(en)
*
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
EP1865061A3
(en)
*
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US7019115B2
(en)
|
1998-05-22 |
2006-03-28 |
Genentech, Inc. |
Pro1017 polypeptides
|
US6171843B1
(en)
|
1998-06-01 |
2001-01-09 |
Incyte Pharmaceuticals, Inc. |
Human peptidyl-prolyl isomerases
|
CA2331154A1
(en)
|
1998-06-16 |
1999-12-23 |
Human Genome Sciences, Inc. |
Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
|
JP2002520068A
(ja)
*
|
1998-07-15 |
2002-07-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
骨形態形成タンパク質
|
US7220835B2
(en)
|
1998-07-30 |
2007-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP2002532060A
(ja)
*
|
1998-08-31 |
2002-10-02 |
ロン ユー, |
新規なヒトリゾチーム遺伝子、それによりコードされたポリペプチド、およびそれらの作製方法
|
US6844148B1
(en)
|
1998-09-24 |
2005-01-18 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
US6699671B1
(en)
|
1998-09-24 |
2004-03-02 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
ES2318902T3
(es)
|
1998-09-24 |
2009-05-01 |
PHARMACIA & UPJOHN COMPANY LLC |
Secretasa en la enfermedad del alzheimer.
|
WO2000020590A2
(en)
*
|
1998-10-06 |
2000-04-13 |
Incyte Pharmaceuticals, Inc. |
G-protein coupled receptor proteins
|
US20030203446A1
(en)
|
1998-10-07 |
2003-10-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6960433B1
(en)
|
1998-10-19 |
2005-11-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
EP1127122A2
(en)
*
|
1998-10-28 |
2001-08-29 |
Incyte Pharmaceuticals, Inc. |
Growth factor related molecules
|
US6432673B1
(en)
|
1998-12-07 |
2002-08-13 |
Zymogenetics, Inc. |
Growth factor homolog ZVEGF3
|
WO2000034473A2
(en)
*
|
1998-12-10 |
2000-06-15 |
Zymogenetics, Inc. |
Seven transmembrane domain receptor zsig56
|
CA2450402A1
(en)
*
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Methods and compositions for inhibiting cancer cell growth comprising pro224
|
AU2486300A
(en)
*
|
1998-12-30 |
2000-07-31 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and nucleic acids encoding them
|
US7115410B1
(en)
|
1999-02-10 |
2006-10-03 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
US7456007B1
(en)
|
1998-12-31 |
2008-11-25 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
WO2000047618A2
(en)
|
1999-02-10 |
2000-08-17 |
Elan Pharmaceuticals, Inc. |
HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
|
AU2596700A
(en)
*
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
KR20010103046A
(ko)
*
|
1999-03-08 |
2001-11-17 |
제넨테크, 인크. |
면역 관련 질환 치료용 조성물 및 치료 방법
|
AU3737500A
(en)
*
|
1999-03-12 |
2000-09-28 |
Genentech Inc. |
Method of preventing the death of retinal neurons and treating ocular diseases
|
AU4008500A
(en)
*
|
1999-04-06 |
2000-10-23 |
Eli Lilly And Company |
Platelet-derived growth factor related gene and protein
|
EP1169445A2
(en)
*
|
1999-04-09 |
2002-01-09 |
Curagen Corporation |
Human proteins and polynucleotides encoding them
|
US7214656B2
(en)
|
1999-04-28 |
2007-05-08 |
Genentech, Inc. |
PRO792 polypeptides
|
WO2000068247A2
(en)
*
|
1999-05-07 |
2000-11-16 |
Human Genome Sciences, Inc. |
Serine proteases
|
WO2000068266A1
(en)
*
|
1999-05-11 |
2000-11-16 |
Eli Lilly And Company |
Amyloid precursor protein protease and related nucleic acid compounds
|
AU3632600A
(en)
*
|
1999-05-14 |
2000-12-05 |
Genentech Inc. |
Compositions and methods for the treatment of immune related diseases
|
CN1244584A
(zh)
*
|
1999-05-14 |
2000-02-16 |
北京医科大学 |
具有免疫细胞趋化和造血刺激活性的趋化因子
|
AU5850500A
(en)
*
|
1999-07-08 |
2001-01-30 |
Helix Research Institute |
Fatty acid transporter protein and gene encoding the protein
|
US7001766B2
(en)
|
1999-07-20 |
2006-02-21 |
Curagen Corporation |
Nucleic acid sequences encoding human angiopoietin-like polypeptides
|
KR100543857B1
(ko)
*
|
1999-09-01 |
2006-01-23 |
제넨테크, 인크. |
혈관신생 및 심혈관형성의 촉진 또는 억제
|
US6429303B1
(en)
*
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
CA2389916A1
(en)
*
|
1999-09-03 |
2001-03-15 |
Human Genome Sciences, Inc. |
B7-like polynucleotides, polypeptides, and antibodies
|
CA2384749A1
(en)
*
|
1999-09-13 |
2001-03-22 |
Curagen Corporation |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
EP1218503A2
(en)
*
|
1999-09-23 |
2002-07-03 |
Whitehead Institute For Biomedical Research |
Fatty acid transport proteins
|
US6780627B1
(en)
*
|
2000-01-31 |
2004-08-24 |
Millennium Pharmaceuticals, Inc. |
22438, 23553, 25278, and 26212 novel human sulfatases
|
WO2001023569A1
(en)
*
|
1999-09-29 |
2001-04-05 |
Hyseq, Inc. |
Cytokine receptor materials and methods
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
CA2388914A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Human Genome Sciences, Inc. |
15 human secreted proteins
|
WO2001036604A2
(en)
|
1999-11-18 |
2001-05-25 |
Corvas International, Inc. |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
US7514408B1
(en)
|
1999-12-02 |
2009-04-07 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
US6682902B2
(en)
*
|
1999-12-16 |
2004-01-27 |
Schering Aktiengesellschaft |
DNA encoding a novel RG1 polypeptide
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
JP2016047051A
(ja)
*
|
1999-12-23 |
2016-04-07 |
ジェネンテック, インコーポレイテッド |
Il−17相同的ポリペプチドとその治療上の用途
|
WO2001053312A1
(en)
*
|
1999-12-23 |
2001-07-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
US7122632B2
(en)
|
1999-12-23 |
2006-10-17 |
Zymogenetics, Inc. |
Soluble Interleukin-20 receptor
|
ATE407950T1
(de)
*
|
1999-12-23 |
2008-09-15 |
Zymogenetics Inc |
Löslicher interleukin-20 rezeptor
|
ATE519847T1
(de)
*
|
1999-12-23 |
2011-08-15 |
Genentech Inc |
Il-17-homologe polypeptide und ihre therapeutische verwendung
|
US7122328B2
(en)
*
|
2000-01-05 |
2006-10-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene involved in mineral deposition and uses thereof
|
US7119165B2
(en)
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
CZ20022438A3
(cs)
*
|
2000-01-12 |
2002-10-16 |
Yale University |
Nukleová kyselina kódující receptor Nogo, izolovaný polypeptid a farmaceutický přípravek pro stimulaci růstu axonů
|
WO2001055214A2
(en)
*
|
2000-01-25 |
2001-08-02 |
Novartis Ag |
Asthma-associated gene
|
ATE496123T1
(de)
*
|
2000-02-03 |
2011-02-15 |
Dendreon Corp |
Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden
|
US6653448B1
(en)
*
|
2000-03-29 |
2003-11-25 |
Curagen Corporation |
Wnt-7B-like polypeptides and nucleic acids encoding same
|
WO2001096392A2
(en)
*
|
2000-06-15 |
2001-12-20 |
Millennium Pharmaceuticals, Inc. |
22109, a novel human thioredoxin family member and uses thereof
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
WO2001079466A2
(en)
*
|
2000-04-18 |
2001-10-25 |
Bayer Aktiengesellschaft |
Regulation of human epithin-like serine protease
|
EP1280923A2
(en)
*
|
2000-04-28 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
14094, a human trypsin family member and uses thereof
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
DE60132699T2
(de)
|
2000-06-06 |
2009-01-29 |
Bristol-Myers Squibb Co. |
Nukleinsäuren und polypeptide, die sich auf b7 beziehen und ihre verwendungen zur immunmodulierung
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
AU2001275310A1
(en)
*
|
2000-06-06 |
2001-12-17 |
Millennium Pharmaceuticals, Inc. |
46980, a novel human neuroligin family member and uses thereof
|
EP1309620A2
(en)
*
|
2000-06-23 |
2003-05-14 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2042597B1
(en)
*
|
2000-06-23 |
2014-05-07 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
JP2015037408A
(ja)
*
|
2000-07-20 |
2015-02-26 |
ジェネンテック, インコーポレイテッド |
血管形成に関連する障害を診断及び治療するための組成物と方法
|
AU2002224546A1
(en)
*
|
2000-07-21 |
2002-02-05 |
Bristol-Myers Squibb Company |
Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof
|
JP5015404B2
(ja)
|
2000-08-08 |
2012-08-29 |
ザイモジェネティクス, インコーポレイテッド |
可溶性zcytor11サイトカイン受容体
|
CA2420193A1
(en)
*
|
2000-08-24 |
2002-02-28 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
CA2420140A1
(en)
*
|
2000-08-24 |
2002-02-28 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
WO2002022683A1
(fr)
*
|
2000-09-12 |
2002-03-21 |
Kirin Beer Kabushiki Kaisha |
Nouvelle membrane a paroi cellulaire dendritique et son utilisation
|
US7855269B2
(en)
|
2000-09-15 |
2010-12-21 |
Zymogenetics, Inc. |
Method for treating inflammation
|
EP1325020A4
(en)
*
|
2000-09-20 |
2004-12-15 |
Human Genome Sciences Inc |
21 HUMANE SECONDED PROTEINS
|
AU2001229563A1
(en)
*
|
2000-09-20 |
2002-04-02 |
Human Genome Sciences, Inc. |
21 human secreted proteins
|
AU2001293046A1
(en)
*
|
2000-09-25 |
2002-04-08 |
Millennium Pharmaceuticals, Inc. |
M32404, a novel human trypsin and uses thereof
|
ATE458815T1
(de)
|
2000-10-06 |
2010-03-15 |
Univ Yale |
Homologe des nogo rezeptors
|
EP1201681A1
(en)
|
2000-10-30 |
2002-05-02 |
Millennium Pharmaceuticals, Inc. |
"Fail" molecules and uses thereof
|
PT1790728E
(pt)
*
|
2000-11-06 |
2010-11-12 |
Cancer Rec Tech Ltd |
Imagiologia, diagnóstico e tratamento de doença
|
US20020111302A1
(en)
*
|
2000-11-30 |
2002-08-15 |
Y. Tom Tang |
Novel nucleic acids and polypeptides
|
JPWO2002057448A1
(ja)
*
|
2000-12-27 |
2004-05-20 |
第一ファインケミカル株式会社 |
新規ペプチド及びその活性
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US20040038860A1
(en)
|
2002-05-17 |
2004-02-26 |
Allen Kristina M. |
Reagents and methods for modulating dkk-mediated interactions
|
PL370105A1
(en)
*
|
2001-05-25 |
2005-05-16 |
Amgen, Inc. |
B7 related protein-2 molecules and uses thereof
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
EP1402070B1
(en)
*
|
2001-06-27 |
2012-01-11 |
Cancer Research Technology Limited |
Methods for the diagnosis of cancer based on the obcam and ntm genes
|
AU2002315525A1
(en)
*
|
2001-07-03 |
2003-01-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
|
WO2003008589A1
(en)
*
|
2001-07-18 |
2003-01-30 |
Asahi Kasei Kabushiki Kaisha |
Elk1 PHOSPHORYLATION-ASSOCIATED GENE
|
WO2003099318A2
(en)
|
2002-05-29 |
2003-12-04 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
EP1469877A4
(en)
*
|
2001-11-02 |
2008-08-20 |
Tanox Inc |
B-cell lymphoma-specific antigen for use in the diagnosis and treatment of malignant B cell lesions
|
WO2003051384A1
(en)
|
2001-12-17 |
2003-06-26 |
Zymogenetics, Inc. |
Method for treating cervical cancer
|
AU2003226131A1
(en)
|
2002-03-28 |
2003-10-13 |
Bristol-Myers Squibb Company |
Novel human cell surface protein with immunoglobulin folds, bgs-19
|
PT1565489E
(pt)
|
2002-06-19 |
2011-02-23 |
Raven Biotechnologies Inc |
Anticorpos internalizantes específicos para o alvo de superfície celular raag10
|
WO2004046191A2
(en)
|
2002-11-20 |
2004-06-03 |
Cancer Research Technology Limited |
Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis
|
US20040203132A1
(en)
|
2003-02-28 |
2004-10-14 |
Cognetix, Inc. |
Conus protein disulfide isomerase
|
EA009026B1
(ru)
|
2003-03-24 |
2007-10-26 |
Займоджинетикс, Инк. |
Антитела против il-22ra, их партнеры по связыванию и способы их применения при воспалениях
|
NZ544911A
(en)
|
2003-07-22 |
2008-12-24 |
Schering Ag |
RG1 antibodies and uses thereof
|
ATE447587T1
(de)
|
2003-11-21 |
2009-11-15 |
Zymogenetics Inc |
Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
|
US7867699B2
(en)
|
2004-03-23 |
2011-01-11 |
Wyeth |
Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby
|
CN102895663A
(zh)
*
|
2004-04-14 |
2013-01-30 |
健泰科生物技术公司 |
含有用于调节血管发育的egfl7拮抗剂的组合物及方法
|
US20080305106A1
(en)
*
|
2004-05-12 |
2008-12-11 |
Jane Brennan |
Novel Gene Disruptions, Composition and Methods Relating Thereto
|
EP1773884B1
(en)
|
2004-08-03 |
2012-03-07 |
Innate Pharma |
Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor
|
MX2007001221A
(es)
|
2004-08-04 |
2007-03-23 |
Amgen Inc |
Anticuerpos para proteina dickkopf-1 (dkk-1).
|
MX2007004770A
(es)
|
2004-10-22 |
2007-11-22 |
Zymogenetics Inc |
Anticuerpos anti-il-22ra y moleculas y metodos para usarlos en inflamacion.
|
DE502004006789D1
(de)
|
2004-11-25 |
2008-05-21 |
Roche Diagnostics Gmbh |
Vorrichtung zum Analysieren von Proben
|
CA2589487C
(en)
|
2004-11-29 |
2014-07-29 |
Klinikum Der Universitat Regensburg |
Means and methods for detecting methylated dna
|
AU2005308916B2
(en)
|
2004-11-29 |
2011-07-21 |
Sequenom, Inc. |
Kits and methods for detecting methylated DNA
|
WO2007008732A2
(en)
|
2005-07-07 |
2007-01-18 |
Yale University |
Compositions and methods for suppressing axonal growth inhibition
|
WO2007019859A2
(en)
|
2005-08-16 |
2007-02-22 |
Novozymes A/S |
Polypeptides of strain bacillus sp. p203
|
KR20180002911A
(ko)
|
2005-11-04 |
2018-01-08 |
제넨테크, 인크. |
안질환 치료를 위한 보체 경로 억제제의 용도
|
AU2006335053A1
(en)
*
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
US7776573B2
(en)
|
2006-06-01 |
2010-08-17 |
Genentech, Inc. |
Crystal structure of CRIg and C3b:CRIg complex
|
WO2008003748A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Novo Nordisk A/S |
Cd300lg polypeptides and their use in treating autoimmune diseases
|
KR20160092061A
(ko)
|
2006-11-02 |
2016-08-03 |
제넨테크, 인크. |
인간화 항-d 인자 항체
|
WO2008100805A2
(en)
|
2007-02-09 |
2008-08-21 |
Genentech, Inc. |
Anti-robo4 antibodies and uses therefor
|
JP2010133705A
(ja)
*
|
2007-03-16 |
2010-06-17 |
Perseus Proteomics Inc |
癌の診断薬及び治療薬
|
AR066660A1
(es)
|
2007-05-23 |
2009-09-02 |
Genentech Inc |
Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
|
WO2009151717A2
(en)
|
2008-04-02 |
2009-12-17 |
Macrogenics, Inc. |
Bcr-complex-specific antibodies and methods of using same
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
WO2009136286A2
(en)
|
2008-05-05 |
2009-11-12 |
Novimmune Sa |
Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
|
RU2553517C2
(ru)
|
2008-05-06 |
2015-06-20 |
Дженентек, Инк. |
Варианты crig с созревшей аффинностью
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
WO2010128407A2
(en)
|
2009-05-05 |
2010-11-11 |
Novimmune S.A. |
Anti-il-17f antibodies and methods of use thereof
|
TWI428142B
(zh)
|
2009-05-08 |
2014-03-01 |
Genentech Inc |
人類化之抗-egfl7抗體及其使用方法
|
KR101471239B1
(ko)
|
2009-05-12 |
2014-12-09 |
화이자 인코포레이티드 |
항-dkk-1 항체의 차단 및 그의 용도
|
WO2011020024A2
(en)
|
2009-08-13 |
2011-02-17 |
The Johns Hopkins University |
Methods of modulating immune function
|
EP3708190A1
(en)
|
2010-02-26 |
2020-09-16 |
Novo Nordisk A/S |
Stable antibody containing compositions
|
CA2791658C
(en)
|
2010-03-04 |
2019-10-01 |
Macrogenics, Inc. |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
US20130136733A1
(en)
|
2010-05-28 |
2013-05-30 |
Novo Nordisk A/S |
Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
CN107318267B
(zh)
|
2013-08-12 |
2021-08-17 |
豪夫迈·罗氏有限公司 |
用于治疗补体相关的病症的组合物和方法
|
BR112016025312A2
(pt)
|
2014-05-01 |
2017-10-17 |
Genentech Inc |
variantes de anticorpo, anticorpo anti-fator d, formulação farmacêutica, dispositivo de distribuição, utilização da formulação e de uma composição, composição e método de tratamento de uma desordem
|
JP2018534930A
(ja)
|
2015-10-30 |
2018-11-29 |
ジェネンテック, インコーポレイテッド |
抗d因子抗体及びコンジュゲート
|
CN108472382A
(zh)
|
2015-10-30 |
2018-08-31 |
豪夫迈·罗氏有限公司 |
抗-因子d抗体变体缀合物及其用途
|
SG11201808979UA
(en)
|
2016-04-15 |
2018-11-29 |
Macrogenics Inc |
Novel b7-h3 binding molecules, antibody drug conjugates thereof and methods of use thereof
|
SG11201906735RA
(en)
|
2017-01-23 |
2019-08-27 |
Regeneron Pharma |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
KR20200062314A
(ko)
|
2017-10-11 |
2020-06-03 |
리제너론 파마슈티칼스 인코포레이티드 |
Pnpla3 i148m 변이를 발현하는 환자의 간 질환의 치료에서의 hsd17b13의 저해
|
CN109708935A
(zh)
*
|
2018-12-15 |
2019-05-03 |
济南艾迪康医学检验中心有限公司 |
一种高分辨外周血染色体g带的制作方法
|